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Edited by Jesus AvilaAbstract The presence of ionotropic P2X7 receptor has been
studied in mice brain from wild type and P2X7 receptor knockout
animals. Western blot and immunocytochemical assays show the
presence of a protein containing the P2X7 immunogenic epitopes
in the brain of knockout model. Reverse transcriptase polymer-
ase chain reaction experiments demonstrate the absence of the
disrupted sequence, but other sequences of P2X7 speciﬁc mRNA
expression have been detected. Functional calcium imaging
experiments in cultured granule neurons from P2X7 knockout
cerebella show the existence of a functional P2X7-like receptor
that keeps some of the properties of the genuine receptor.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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2 03 0-O-(4-Benzoylbenzoyl)-adenosine 5 0-triphosphate1. Introduction
Ionotropic P2X receptors for adenosine 5 0-triphosphate
(ATP) are formed, to date, by seven diﬀerent subunits, named
P2X17, cloned from various mammalian species [1,2]. P2X
subunits are formed by two transmembrane domains, a large
extracellular loop containing the ATP binding site and intra-
cellular N and C terminal tails [3]. These subunits may occur
as homo- or hetero-oligomeric assemblies of more than one
subunit [4], except P2X7 receptor, which has been described
not to coassemble with other subunits [5].
The relevance of P2X7 in the immune system, where it is nec-
essary for the function of monocytes and macrophages,
encouraged the generation of a P2X7 knockout (KO) mice,
which was very useful to demonstrate its role in interleukine
production [6]. On the other hand, P2X7 polymorphisms inAbbreviations: ATP, adenosine 5 0-triphosphate; BSA, bovine serum
albumin; BzATP, 2 03 0-O-(4-benzoylbenzoyl)-adenosine 5 0-triphos-
phate; CNS, central nervous system; div, days in vitro; EGTA, ethyl-
ene glycol-bis(2-amino-ethyleter)-N,N,N 0,N0-tetraacetic acid; HEPES,
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; KO, knockout;
PBS, phosphate buﬀer saline; PFA, paraformaldehyde; PVDF, poly-
vinylidene diﬂuoride; RT-PCR, reverse transcriptase polymerase chain
reaction; SDS, sodium dodecyl sulfate; TRITC, tetramethylrhodamine
isothiocyanate; WT, wild type
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doi:10.1016/j.febslet.2005.05.073humans have been described and a role in the prognosis of
chronic lymphocytic leukemia reported [7].
The expression of P2X7 receptor in nervous system is not
clear. Studies have shown the protein expression in synaptic
terminals of central nervous system (CNS) [8–10], cerebellum
[9,11], hippocampus [12,13], as well as, in neuromuscular junc-
tion in the peripheral nervous system [8]. However, other
authors do not ﬁnd P2X7 expression in rodent CNS [14].
As P2X7 receptor KO mice are viable and fertile [6], it was
possible to undertake parallel studies trying to demonstrate
the presence and functionality of P2X7 receptor in wild type
(WT) and to compare with the KO animals.
Surprisingly, immunocytochemical and reverse transcriptase
polymerase chain reaction (RT-PCR) experiments indicate the
presence of a P2X7-like protein in KO animals. Besides, cal-
cium imaging studies carried out in cultured granule neurons
show the presence of P2X7 responses in WT and a similar
but not identical response in P2X7 KO animals.2. Materials and methods
All experiments carried out at the Universidad Complutense de
Madrid followed the guidelines of the International Council for Labo-
ratory Animal Science (ICLAS).
We have used male P2X7 KO mice derived from Pﬁzer (Groton, CT,
USA) generated by Solle et al. [6] and male C57B1/6J mice (WT). The
KO animals had disrupted the region from T1527 to T1605, located at
exon 13. The animals were 60–90 days old, except for cerebellar cell
cultures.
2.1. Synaptosomal preparation
Mice were cervically dislocated, decapitated and the cortex, mid-
brain and cerebellum were removed. The synaptosomal isolation was
made following the procedure described by Dunkley et al. [15].
2.2. Cellular cultures
Primary cerebellar cultures were obtained from six cerebella of 7
days old mouse pups as described previously [16]. Neurons were plated
onto 60 mm culture dishes pre-coated with poly-L-lysine at a density of
1.5 · 106 cells/plate and were maintained in a humidiﬁed incubator at
37 C in 5% CO2. Peritoneal macrophages cultures were obtained as
described [17].
2.3. Western blotting
Western blot experiments were performed using synaptosomal pro-
teins extracted from cortex, midbrain, cerebellum and from cultured
macrophages, as previously described [18]. Membranes were incubated
overnight at 4 C with every one of the three diﬀerent commercial anti-
bodies that recognize the intracellular epitope (from Arg576 to Tyr595)
from Alomone Labs (Jerusalem, Israel) at 1:5000 dilution, BD PharM-
ingen (Franklin Lakes, NJ, USA) at 1:5000 dilution and Chemicon
(Temecula, CA, USA) at 1:500 dilution. We also used a primaryblished by Elsevier B.V. All rights reserved.
Fig. 1. P2X7 expression in brain (A) and in peritoneal macrophage (B)
proteins from WT and KO mice. 50 lg of isolated proteins from
cerebellum and 450 lg of peritoneal macrophage proteins were
fractionated by sodium dodecyl sulfate (SDS)–polyacrilamide gel
electrophoresis and then transferred to polyvinylidene diﬂuoride
(PVDF) membranes. We used four diﬀerent primary antibodies,
ﬁnding similar results with all of them. This ﬁgure shows the Western
blot corresponding to the primary antibody from Alomone Labs.,
intracellular epitope. Ab, antibody. Control, control antigen.
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Cys152), from Alomone Labs at 1:1000 dilution. As secondary anti-
body, incubated 1 h at room temperature, we used anti-rabbit IgG per-
oxidase linked (Amersham Bioscience; Uppsala, Sweden), at 1:5000
dilution in all cases. Incubation with the control antigen was made fol-
lowing the manufacturer instructions.
2.4. RT-PCR and DNA sequencing experiments
Total RNA from cortex, midbrain and cerebellum was isolated using
the RNeasy system (Mini-kit; Qiagen, Hilden, Germany). RNA isola-
tion and RT experiments were made as previously described [11].
PCRs were carried out using 0.625 U Ampli Taq Gold DNA poly-
merase (Applied Biosystems; Foster City, CA, USA), in the presence
of 3 mMMgCl2, dNTP mixture (0.2 mM each), speciﬁc P2X7 oligonu-
cleotide primers (300–600 nM each), and 2–5 lL of the RT product.
After a 10 min hold at 95 C (required for Ampli TaqGold DNA poly-
merase activation), the ampliﬁcation was run for 40 cycles (95 C, 30–
90 s; 55–60 C, 30–60 s; and 72 C, 45–60 s). Control reactions (H2O
control) were done in the absence of RT product (template) to avoid
cross contamination. Speciﬁc primers for P2X7 were designed in our
laboratory and are summarised in Table 1.
PCR ampliﬁcation products were electrophoresed on a 1.5–2% (w/v)
agarose gel and stained with SYBR Gold probe (Molecular Probes;
Eugene, OR, USA).
To develop the analysis sequence, the PCR products obtained using
mp2x7 extra primers in both animals were puriﬁed with QUIAquick
kit. The DNA sequencing was carried out using BigDye Terminator
v3.1 Cycle Sequencing kit and 3770 DNA Analyser (Applied Biosys-
tems). The comparative analysiswasmadeusingChromas 2.24 software.
2.5. Immunocytochemistry
Granule cerebellar cells were treated with paraformaldehyde (PFA)
4% (w/v) for 15 min, washed twice with phosphate buﬀer saline (PBS)
and incubated for 1 h in PBS containing bovine serum albumin (BSA)
3% (w/v), Triton X-100 0.1% (v/v) and normal goat serum 5% (v/v). As
primary antibodies we used the same four antibodies described above,
all of them used at 1:200 dilution. As secondary antibody we used
TRITC-coupled goat anti-rabbit IgG (Sigma; Saint Louis, MI,
USA), at 1:500 dilution. Incubation with primary and secondary anti-
bodies was done at 37 C during 1 h. Incubation with the control anti-
gen was made following the manufacturer instructions. Controls were
performed following the same procedure but replacing primary anti-
bodies by the same volume of PBS–BSA solution.
2.6. Calcium imaging
Granule cerebellar cells were washed, under normal K+ conditions,
with Lockes solution (composition in mM: NaCl, 140; KCl, 4.5;
CaCl2, 2.5; KH2PO4, 1.2; MgSO4, 1.2; glucose, 5.5 and 4-(2-hydroxy-
ethyl)-1-piperazineethanesulfonic acid [HEPES; acid], 10; pH 7.4) sup-
plemented with 1 mg/mL BSA, and loaded with Fura-2 AM (7.5 lM)
for 45 min at 37 C. Cells were placed in a small superfusion chamber
and superfused ﬁrst with Lockes solution, and after with 100 lMATP
(physiologic agonist) or with 100 lM 2 03 0-O-(4-benzoylbenzoyl)-aden-
osine 5 0-triphosphate (BzATP; synthetic agonist) in the absence of
MgCl2 in the Lockes solution.
In other set of experiments, the cells were superfused with ZnSO4
100 lM (P2X7 receptor inhibitor) and with 600 lM ATP, both in the
absence of MgCl2, and washed afterwards during 6 min with Lockes
solution, in absence of MgCl2, before a new superfusion with
600 lM ATP.Table 1
Three speciﬁc primer pairs: mp2x7 disrupted, which ampliﬁes a region that in
for a region that includes the sequence codifying for the extracellular epitope
epitope (A1737–A1795)
Forward primer
mp2x7 disrupted TGCATCACCACCTCCAAGCTCTTCCAT
mp2x7 extra GCACGAATTATGGCACCGTC
mp2x7 intra AGGATCCGGAAGGAGTT
These primers were designed in our laboratory based on speciﬁc mouse P2XA pulse of 30 mM KCl (in the presence of MgCl2) was applied at the
end of each experiment to conﬁrm the functionality and viability of the
cells.
Granule neurons were imaged through a NIKON TE-200 micro-
scope 100· lens (S Fluor 0.5–1.3 oil iris). The incoming light was set
at 340 and 380 nm. These wavelengths correspond to the ﬂuorescence
peaks of Ca2+-saturated and Ca2+-free Fura-2 AM solutions. Images
were obtained using an ORCA-ER C 47 42-80 camera from Hamama-
tsu (Hamamatsu City, Japan) controlled by MetaFluor 6.2r6 PC soft-
ware (Universal Imaging Corp., Cambridge, UK).
Background and autoﬂuorescence components were subtracted at
each wavelength and the ratio 340/380 was calibrated into [Ca2+]i val-
ues using the Grynkiewiczs equation [19]. The variables Rmax, Rmin
and b were calculated as previously described [20].3. Results
3.1. P2X7 receptor expression in WT and KO mice by Western
blotting
Western blot experiments were developed using synaptoso-
mal proteins extracted from WT and KO brain mice, to con-
ﬁrm the validity of the KO model. Surprisingly, we ﬁnd no
diﬀerences in the results obtained with both animals. As can
be observed in Fig. 1A, two bands of 65 and 77 kDa appeared
in Western blot from isolated cerebellar membranes, as also in
membranes from cortex and midbrain (results not shown).
The binding of the antibodies to both polypeptide bands in
cerebellar membranes, detected by Western blot, was elimi-
nated with the control antigen peptide incubation (Fig. 1A).
This shows clearly the presence, in both protein bands, of acludes the absent region in the KO mice (T1517-G1616); mp2x7 extra,
(G79-T468); mp2x7 intra, for the region that codify for the intracellular
Reverse primer Tm (C)
CACCAGCAAGGGATCCTGGTAAAGC 58
ACACCTGCCAGTCTGGATTCCT 60
TAGGGATACTTGAAGCCACT 55
7 sequence. Tm, temperature of melting.
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ate the antibodies.
With these results, we asked if the commercial antibodies
used in our study were really recognizing only the P2X7 sub-
unit. Solle and co-workers [6], using one of the antibodies used
by us in this study, have shown the presence of the P2X7 recep-
tor in WT but not in KO mice. In similar Western blot exper-
iments with proteins extracted from macrophages appeared, as
shown in Fig. 1B, a band of 77 kDa in WT but not in KO mac-
rophages. Moreover, in KO macrophages no other molecular
weight band was found, which agree with Solle et al. [6].3.2. RT-PCR and DNA sequencing
RT-PCR experiments were carried out using three diﬀerent
pairs of primers (Table 1). As can be observed in Fig. 2A, when
the primers that codify for the disrupted sequence were used in
the KO mice (mp2x7 disrupted), this DNA fragment appeared
only in WT mice, as previously reported [6]. However, when
we used the primers that codify for the regions that include
the epitopes recognized by the anti-P2X7 receptor antibodies
(mp2x7 intra, for the intracellular epitope and mp2x7 extra,
for the extracellular epitope) the expected bands appeared in
the DNA preparations of WT mice, as well as in DNA prepa-
rations of KO mice (Fig. 2A).
The DNA sequencing analysis showed no diﬀerences in the
speciﬁc region from G79 to T468 between both animals in
all areas tested (Fig. 2B).3.3. P2X7 immunocytochemical and functional characterization
of WT and KO cerebellar granule cells
To conﬁrm the presence of the P2X7 protein we achieved, in
9 days in vitro (div) granule cells, immunocytochemical stain-Fig. 2. (A) Analysis of the P2X7 expression by RT-PCR in DNA preparation
and midbrain (not shown). M, 100-bp DNA ladder. H2O, control carried out
bp (from G79 to T468), obtained in cerebellum WT and KO mice, using mp2
A213, as an example. The complete sequences were identical in cerebellum W
both animals (not shown).ing with the four primary antibodies. We detected the presence
of this protein in ﬁbres and in somas of both mice (Figs. 3A
and 4A1). When cells were incubated with the control antigen,
the staining was completely abolished (Fig. 4A2), indicating
that the labelling observed in the immunocytochemical prepa-
rations is due exclusively to the epitope recognized by the pri-
mary antibodies.
To assess that cultured neurons express functional P2X7
receptors, we carried out calcium imaging assays. 9 div cells were
stimulated with the physiological agonist, ATP, and with more
speciﬁc synthetic agonist, BzATP [1], both in absence of magne-
sium. We found response to both compounds, being greater the
response due to BzATP. In WT the D[Ca2+]i is of 162.84 ±
19.21 nM in response to BzATP vs. 109.06 ± 10.79 nM in re-
sponse to ATP (Fig. 3B1). In KO cells the D[Ca2+]i is of
93.85 ± 12.69 nM in response to BzATP vs. 74.16 ± 9.99 nM
in response toATP (Fig. 4B1).However, diﬀerent kinetic behav-
iour in the response to both agonists between granule cells from
WT and from KO animals was observed. WT granule cells kept
their Ca2+ response until the agonists were washed out (Fig.
3B1), unlike KO granule cells, that recovered their basal
[Ca2+]i before withdrawal of the agonists (Fig. 4B1).
As Zn2+ ions have been described as inhibitors of genuine
P2X7 receptor [21], studies were carried out in the presence
of ZnSO4. In Figs. 3B2 and 4B2, it can be observed that
Zn2+ ions completely abolished the ATP response, along the
granule neurons ﬁbres.
Calcium imaging assays carried out in the presence of 6 mM
ethylene glycol-bis(2-amino-ethyleter)-N,N,N 0,N 0-tetraacetic
acid (EGTA; a calcium sequestrator) showed no response to
ATP in both mouse types (data not shown). This excludes
the possibility that the responses found were mediated by a
metabotropic P2Y receptor.s from WT and KO cerebella. The same results were obtained in cortex
in the absence of template. (B) DNA sequencing of PCR product of 389
x7 extra primers. This chromatogram shows a fragment from C195 to
T and KO mice. Similar results were found in cortex and midbrain of
Fig. 3. (A) Immunolocalization of P2X7 receptor in 9 div cerebellar granule cells of WT mouse. This image correspond to the immunostaining with
the primary antibody from Alomone Labs., intracellular epitope. Similar results were obtained with the other primary antibodies tested. The white
squares represent the typical ﬁbres analysed in calcium imaging experiments showed in (B). Scale bar = 50 lm. (B) Calcium responses in WT granule
cells. (B1) Response to ATP 100 lM and to BzATP 100 lM, in diﬀerent experiments. (B2) Response to ATP 600 lM in the presence and in the
absence of ZnSO4. Cells were challenged with KCl 30 mM at the end of every experiment. Each response represents the mean ± S.E.M. of three
diﬀerent cellular cultures and roughly 2000 regions analysed. We only studied regions along the ﬁbres located at 10–15 lm far away of the somas,
with areas of 0.8–3 lm2.
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The experimental work reported here, demonstrates the exis-
tence of functional P2X7 receptor in cultured granule cells
from cerebellum in WT mice, and the presence of a similar
receptor, a P2X7-like, also functional in P2X7 KO animals.
KO models are very useful to understand the functionality
and main role of diverse proteins, and in some cases allow
identifying other proteins with structural or functional analo-
gies. This appears to be the case of P2X7 KO. The absence
of P2X7 receptor expression in the KO model has been tested
in diﬀerent cells such as peritoneal macrophages [6], leukocytes
[22], osteoclasts, osteoblasts [23] and submandibular ductal
cells [24]. In good agreement with these reference data, we have
found P2X7 expression in Western blot from WT, but no in
P2X7 KO macrophages (Fig. 1B).
However, a diﬀerent situation occurs in mice brain, as al-
ready noticed [14,25]. In Western blot experiments, two bands
of diﬀerent molecular weights were present in WT and, unex-
pectedly, in KO animals (Fig. 1A). The 65 kDa one is consis-
tent with the predicted molecular weight of the mouse P2X7subunit, in accordance with the aminoacidic sequence. The
77 kDa band may correspond to a modiﬁed form of the pro-
tein, such as glycosylated forms. Moreover, cultured granule
neurons from both animals show a very similar immunostain-
ing pattern (Figs. 3A and 4A1), and in both cases the control
peptide completely abolished P2X7 immunolabelling. This sug-
gests that all recognized proteins contain the antigenic epitope
and they should have strong homology sequence.
On the other hand, RT-PCR assays show a clear distinction
between WT and KO mice for the disrupted region of the KO
(Fig. 2A), which conﬁrms the validity of KO model. Moreover,
we have not observed diﬀerences between both animals in the
DNA regions that codify for the epitopes recognized by the
commercial antibodies (Fig. 2), which agrees with the immuno-
staining pattern from both animals.
The sequencing data and antibodies labelling to the extracel-
lular epitope points to an identical sequence, till the Ser23 to
Cys152. In spite of the absence of the deleted sequence in the
KO model, Cys506 to Pro532, a very similar sequence have to
exist at the carboxy-terminal that is recognized by the same
antibodies, directed to the epitope from Arg576 to Tyr595.
Fig. 4. (A) Immunolocalization of P2X7 receptor in 9 div cerebellar granule cells of KO mouse. (A1) Immunostaining with the Alomone Labs.,
intracellular epitope as primary antibody. White squares, as in Fig. 3. (A2) immunostaining with the primary antibody preincubated with de control
antigen. Scale bar = 50 lm. (B) Calcium responses in KO granule cells. (B1, B2) Assay conditions are as that in Fig. 3.
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and functionality of P2X7 receptor in CNS [8–14]. Previous re-
sults from our laboratory demonstrate the existence of func-
tional P2X7 at the midbrain and cerebellar synaptic terminals
[9,26], and a very abundant labelling in cultures of rat granule
neurons, where it colocalizes with synaptophysin [11]. Calcium
imaging experiments carried out in mice granule cells conﬁrm
that the P2X7 receptor expressed in WT brain behaves as a typ-
ical functional P2X7 receptor (Figs. 3B1 and B2), in accor-
dance with the reported pharmacology [1]. BzATP is more
potent agonist than ATP at the same concentration, and
Zn2+ inhibits the calcium inﬂux through the channel [21]. We
have found a similar behaviour in KO granule cells (Figs.
4B1 and B2), but with diﬀerent kinetic properties. While the
Ca2+ response are maintained all along of the agonist presence
in WT mice, the response in KO decreases before washing out
the agonist, which suggest that this receptor is undergoing
desensitization. These diﬀerences could be explained by the
existence of a P2X7-like receptor that keeps some analogies
but not identical with genuine P2X7 receptor. It is to notice
that perfusion media are continuously renovated, which imply
that there is not enough time to allow the possible eﬀect of the
ATP hydrolysis products.In our study, the presence of functional P2X7 receptor was
demonstrated in WT brain. To explain the results obtained
in KO brain, we suggest that it may exist a protein very similar
to P2X7, but with a functional behaviour slightly diﬀerent. It is
necessary to keep in mind that P2X7 pore requires the trans-
membrane segment two and there is still no data concerning
the sequence homology between KO and WT, which could
stand for the kinetic diﬀerences. It could be possible that the
protein expressed in KO brain could be a ‘‘novel’’ protein,
or the product of an unknown alternative splicing of the gene
that codify for the P2X7 receptor. Other explanations could be
possible and will be necessary deeper studies to characterize
this ‘‘P2X7-like receptor’’ unknown until now.Acknowledgements: P.M.G. is a research fellow of Ministry of Educa-
tion and Science. This work is supported by grants of the Spanish
Ministry of Education and Science, BFI2002-03626 and CAM No.
GR/SAL 551-04.
The authors thank to Dr. C.A. Gabel (from Pﬁzer Inc., Groton, CT,
USA) forKOgeneration and toDr. J.P.Dehaye (Laboratoire de Biochi-
mie et de Biologie Cellulaire, Institut de Pharmacie, Universite´ Libre de
Bruxelles, Brussels, Belgium) for his generous gift of the P2X7 KOmice.
The authors are very grateful to Dr. Luis Rivas for his help in mac-
rophages cultures.
3788 J. Sa´nchez-Nogueiro et al. / FEBS Letters 579 (2005) 3783–3788References
[1] North, R.A. (2002) Molecular physiology of P2X receptors.
Physiol. Rev. 82, 1013–1067.
[2] Illes, P. and Ribeiro, J.A. (2004) Molecular physiology of P2
receptors in the central nervous system. Eur. J. Pharmacol. 483,
5–17.
[3] Khakh, B.S., Burnstock, G., Kennedy, C., King, B.F., North,
R.A., Seguela, P., Voigt, M. and Humphrey, P.P. (2001)
International union of pharmacology. XXIV. Current status of
the nomenclature and properties of P2X receptors and their
subunits. Pharmacol. Rev. 53, 107–118.
[4] North, R.A. and Surprenant, A. (2000) Pharmacology of cloned
P2X receptors. Ann. Rev. Pharmacol. Toxicol. 40, 563–580.
[5] Torres, G.E., Egan, T.M. and Voigt, M.M. (1999) Hetero-
oligomeric assembly of P2X receptor subunits. Speciﬁcities exist
with regard to possible partners. J. Biol. Chem. 274, 6653–6659.
[6] Solle, M., Labasi, J., Perregaux, D.G., Stam, E., Petrushova, N.,
Koller, B.H., Griﬃths, R.J. and Gabel, C.A. (2001) Altered
cytokine production in mice lacking P2X7 receptors. J. Biol.
Chem. 276, 125–132.
[7] Willey, J.S., Dao-Ung, L.P., Li, C., Shemon, A.N., Gu, B.J.,
Smart, M.L., Fuller, S.J., Barden, J.A., Petrou, S. and Sluyter, R.
(2003) An Ile-568 to Asn polymorphism prevents normal
traﬃcking and function of the human P2X7 receptor. J. Biol.
Chem. 278, 17108–17113.
[8] Deuchars, S.A., Atkinson, L., Brooke, R.E., Musa, H., Milligan,
C.J., Batten, T.F., Buckley, N.J., Parson, S.H. and Deuchars, J.
(2001) Neuronal P2X7 receptors are targeted to presynaptic
terminals in the central and peripheral nervous systems. J.
Neurosci. 21, 7143–7152.
[9] Miras-Portugal, M.T., Dı´az-Herna´ndez, M., Gira´ldez, L., Herva´s,
C., Go´mez-Villafuertes, R., Sen, R.P., Gualix, J. and Pintor, J.
(2003) P2X7 receptors in rat brain: presence in synaptic terminals
and granule cells. Neurochem. Res. 28, 1597–1605.
[10] Deng, Z. and Fyﬀe, R.E.W. (2004) Expression of P2X7
receptor immunoreactivity in distinct subsets of synaptic
terminals in the ventral horn of rat lumbar spinal cord. Brain
Res. 1020, 53–61.
[11] Herva´s, C., Pe´rez-Sen, R. and Miras-Portugal, M.T. (2003)
Coexpression of functional P2X and P2Y nucleotide receptors
in single cerebellar granule cells. J. Neurosci. Res. 73, 384–
399.
[12] Kukley, M., Stausberg, P., Adelmann, G., Chessell, I.P. and
Dietrich, D. (2004) Ecto-nucleotidases and nucleoside transport-
ers mediate activation of adenosine receptors on hippocampal
mossy ﬁbers by P2X7 receptor agonist 2
0-30-O-(4-ben-
zoylbenzoyl)-ATP. J. Neurosci. 24, 7128–7139.
[13] Papp, L., Vizi, E.S. and Sperla´gh, B. (2004) Lack of ATP-evoked
GABA and glutamate release in the hippocampus of P2X7
receptor / mice. Neuroreport 15, 2387–2391.[14] Sim, J.A., Young, M.T., Sung, H.Y., North, R.A. and Surpre-
nant, A. (2004) Reanalysis of P2X7 receptor expression in rodent
brain. J. Neurosci. 24, 6307–6314.
[15] Dunkley, P.R., Jarvie, P.E., Heath, J.W., Kidd, G.J. and Rostas,
J.A. (1986) A rapid method for isolation of synaptosomes on
Percoll gradients. Brain Res. 372, 115–129.
[16] Gallo, V., Kingsbury, A., Balazs, R. and Jorgensen, O.S. (1987)
The role of depolarization in the survival and diﬀerentiation of
cerebellar granule cells in culture. J. Neurosci. 7, 2203–2213.
[17] Luque-Ortega, J.R., Martı´nez, S., Saugar, J.M., Izquierdo, L.R.,
Abad, T., Luis, G.J., Pin˜ero, J., Valladares, B. and Rivas, L.
(2004) Fungus-elicited metabolites from plants as an enriched
source for new leishmanicidal agents: antifungal phenyl-phenale-
none phytoalexins from the banana plant (Musa acuminata) target
mitochondria of Leishmania donovani promastigotes. Antimicrob.
Agents Chemother. 48, 1534–1540.
[18] Dı´az-Herna´ndez, M., Go´mez-Villafuertes, R., Hernando, F.,
Pintor, J. and Miras-Portugal, M.T. (2001) Presence of diﬀerent
ATP receptors on rat midbrain single synaptic terminals.
Involvement of the P2X3 subunits. Neurosci. Lett. 301, 159–162.
[19] Grynkiewicz, G., Poenie, M. and Tsien, R.Y. (1985) A new
generation of Ca2+ indicators with greatly improved ﬂuorescence
properties. J. Biol. Chem. 260, 3440–3450.
[20] Dı´az-Herna´ndez, M., Pintor, J., Castro, E. and Miras-Portugal,
M.T. (2001) Independent receptors for diadenosine pentaphos-
phate and ATP in rat midbrain single synaptic terminals. Eur. J.
Neurosci. 14, 918–926.
[21] Virginio, C., Church, D., North, R.A. and Surprenant, A. (1997)
Eﬀects of divalent cations, protons and calmidazolium at the rat
P2X7 receptor. Neuropharmacology 36, 1285–1294.
[22] Labasi, J.M., Petrushova, N., Donova, C., McCurdy, S., Lira, P.,
Payette, M.M., Brissette, W., Wicks, J.R., Audoly, L. and Gabel,
C.A. (2002) Absence of the P2X7 receptor alters leukocyte
function and attenuates an inﬂammatory response. J. Immunol.
168, 6436–6445.
[23] Ke, H.Z., Qi, H., Weidema, A.F., Zhang, Q., Panupinthu, N.,
Crawford, D.T., Grasser, W.A., Paralkar, V.M., Li, M., Audoly,
L.P., Gabel, C.A., Jee, W.S., Dixon, S.J., Sims, S.M. and
Thompson, D.D. (2003) Deletion of the P2X7 nucleotide receptor
reveals its regulatory roles in bone formation and resorption.
Mol. Endocrinol. 17, 1356–1367.
[24] Pochet, S., Go´mez-Mun˜oz, A., Marino, A. and Dehaye, J.P.
(2003) Regulation of phospholipase D by P2X7 receptors in
submandibular ductal cells. Cell. Signal. 15, 927–935.
[25] Marı´n-Garcı´a, P., Sa´nchez-Nogueiro, J., Pe´rez-Sen, R., Miras-
Portugal, M.T., (2004). Presencia de una nueva proteı´na en
cerebro de rato´n knock out para la subunidad P2X7. XXVII
Congreso de la SEBBM.
[26] Herva´s, C., Pe´rez-Sen, R., Miras-Portugal, M.T., (2005). Presence
of diverse functional P2X receptors in rat cerebellar synaptic
terminals. Biochem. Pharmacol., in press.
